Europe Hyperpigmentation Disorder Treatment Market Forecast to 2030

Europe Hyperpigmentation Disorder Treatment Market Forecast to 2030 – Regional Analysis – by Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-inflammatory Hyperpigmentation, and Others), and End User (Hospitals, Dermatology Centers, and Others)

Send Enquiry

$2,485$3,885

Description

The Europe hyperpigmentation disorder treatment market was valued at US$ 1,100.99 million in 2022 and is expected to reach US$ 1,911.95 million by 2030; it is estimated to register a CAGR of 7.1% from 2022 to 2030.

Increasing Number of Hyperpigmentation Disorder Awareness Programs Drives Europe Hyperpigmentation Disorder Treatment Market

Campaigns to raise awareness about UV-induced skin hyperpigmentation are essential to educate the general populace on the prevention, screening, diagnosis, and treatment of these conditions; they also discuss the importance of using good-quality sunscreen products to manage these disorders.
On May 25, 2022, Bella Aurora celebrated the International Skin Pigmentation Day. With over 130 years of experience in the research of skin pigmentation, Bella Aurora launched an international awareness campaign to celebrate the day with the support of renowned dermatologists, pharmacists, and key opinion leaders across the Spain and Italy. In June 2021, Dermalogica Clear launched a campaign to encourage skin acceptance and educate audiences on post-inflammatory hyperpigmentation, acne, breakouts, and more.
The increased awareness of melasma and other hyperpigmentation disorders has led to a surge in demand for innovative and efficacious treatment products and procedures. Moreover, it has brought about a significant and positive change in how society understands and manages hyperpigmentation. Thus, the increasing number of awareness programs bolsters the growth of the hyperpigmentation disorder treatment market.

Europe Hyperpigmentation Disorder Treatment Market Overview

The hyperpigmentation disorder treatment market in Europe is segmented into Germany, UK, France, Italy, Spain, and Rest of Europe. The Germany held the largest Europe hyperpigmentation disorder treatment market share in 2023. Factors such as increasing awareness and emphasis on skincare and dermatological health among the population driving the market growth. Germans are increasingly proactive in seeking advanced skincare solutions to address hyperpigmentation disorders such as melasma, age spots, and post-inflammatory hyperpigmentation, driving the demand for innovative treatments in the market. Additionally, the rise in the aging population in Germany has led to numerous age-related skin concerns, including hyperpigmentation, prompting individuals to seek specialized treatments to maintain radiant skin. According to the Federal Statistical Office of Germany (Statistisches Bundesamt), the number of people aged 67 and above would increase from 4 million to at least 20 million by the mid-2030s. A culture that values skin care and anti-aging solutions, coupled with population aging and high skin disease prevalence, contributes to the demand for hyperpigmentation disorder treatments in Germany. Furthermore, rising attention and concerns about appearance continue to be a key factor in increasing the demand for various cosmetic procedures, contributing to strong market growth. Moreover, the presence of advanced medical infrastructure, skilled dermatologists, and reputable cosmetic clinics in Germany contributes to the accessibility of a wide range of hyperpigmentation treatments and procedures, attracting both domestic and international patients seeking quality skin care services.

Europe Hyperpigmentation Disorder Treatment Market Revenue and Forecast to 2030 (US$ Million)

Europe Hyperpigmentation Disorder Treatment Market Segmentation

The Europe hyperpigmentation disorder treatment market is categorized into treatment type, condition, end user, and country.

Based on treatment type, the Europe hyperpigmentation disorder treatment market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest market share in 2022.

Based on condition, the Europe hyperpigmentation disorder treatment market is segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest market share in 2022.

Based on end user, the Europe hyperpigmentation disorder treatment market is segmented into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022.

By country, the Europe hyperpigmentation disorder treatment market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe hyperpigmentation disorder treatment market share in 2022.

AbbVie Inc, Bayer AG, EpiPharm AG, Galderma SA, L’OREAL S.A., Lutronic Co Ltd, Obagi Cosmeceuticals LLC, and Pierre Fabre SA are some of the leading companies operating in the Europe hyperpigmentation disorder treatment market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 7.1% CAGR, Europe Hyperpigmentation Disorder Treatment Market is Speculated to be Worth US$ 1,911.95 Million by 2030, says Business Market Insights

According to Business Market Insights’ research, the Europe hyperpigmentation disorder treatment market was valued at US$ 1,100.99 million in 2022 and is projected to reach US$ 1,911.95 million by 2030, registering a CAGR of 7.1% from 2022 to 2030. Rise in prevalence of melasma and strategic initiatives by market players are among the critical factors attributed to drive the Europe hyperpigmentation disorder treatment market growth.

Major hyperpigmentation disorder treatment market players focus on research and development activities to develop and launch innovative and efficient products. They are also making efforts to win regulatory approvals for their products. Some of the recent product developments and launches, which are likely to create ample growth opportunities for market players, are mentioned below.

In October 2022, Galderma introduced Skincare A-LUMINATE BRIGHTENING SERUM, a breakthrough product in the skincare industry. This innovative addition to the ALASTIN Skincare range is specifically formulated to lower the appearance of surface hyperpigmentation without the use of harsh or irritating ingredients.

In February 2022, Alchemee introduced the new Restorative Elements brand to help in the correction of the appearance of various types of skin discoloration and hyperpigmentation symptoms, including age spots, sunspots, uneven skin tone, and post-inflammatory hyperpigmentation (PIH). The Restorative Elements is a dermatologist-developed, clinically-proven routine formulated to safely and gently help fade the visible signs of skin hyperpigmentation.

In May 2022, Scientis launched the Cyspera Intensive System, a three-product system formulated to improve hyperpigmentation.
On the contrary, the high cost of treatments hampers the growth of the Europe hyperpigmentation disorder treatment market.

Based on treatment type, the Europe hyperpigmentation disorder treatment market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held 42.7% market share in 2022, amassing US$ 469.64 million. It is projected to garner US$ 845.36 million by 2030 to register 7.6% CAGR during 2022-2030.

Based on condition, the Europe hyperpigmentation disorder treatment market is segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held 47.0% market share in 2022, amassing US$ 517.89 million. It is projected to garner US$ 923.22 million by 2030 to register 7.5% CAGR during 2022-2030.

Based on end user, the Europe hyperpigmentation disorder treatment market is segmented into hospitals, dermatology centers, and others. The hospitals segment held 48.4% market share in 2022, amassing US$ 532.89 million. It is projected to garner US$ 919.22 million by 2030 to register 7.1% CAGR during 2022-2030.

Based on country, the Europe hyperpigmentation disorder treatment market is categorized into Germany, UK, France, Italy, Spain, and Rest of Europe. Our regional analysis states that Germany captured 25.8% share of Europe hyperpigmentation disorder treatment market in 2022. It was assessed at US$ 283.63 million in 2022 and is likely to hit US$ 499.29 million by 2030, registering a CAGR of 7.3% during 2022-2030.

Key players operating in the Europe hyperpigmentation disorder treatment market are AbbVie Inc, Bayer AG, EpiPharm AG, Galderma SA, L’OREAL S.A., Lutronic Co Ltd, Obagi Cosmeceuticals LLC, and Pierre Fabre SA, among others.

In September 2023, Galderma launched a new product, C-RADICAL Defense Antioxidant Serum, a new addition to the ALASTIN Skincare product – This serum is formulated with Vitamin C (Sodium Ascorbate) and 14 essential antioxidants that offers a new option in antioxidant serums to protect against environmental stressors, fight free radicals, UV damage, blue light, and pollution while supporting the skin’s ability to maintain elastin and can help skin look smoother, more radiant, and healthier.

In January 2022, Obagi introduced Skintrinsiq. The skincare device employs Obagi InfuseIQ Technology to raise the topmost layers of the skin, removing impurities and promoting the absorption of Obagi products. Skintrinsiq treatments can be customized to suit all skin types and skin care objectives, ranging from treating fine lines and wrinkles to brightening the skin for a more uniform complexion.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe hyperpigmentation disorder treatment market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe hyperpigmentation disorder treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe hyperpigmentation disorder treatment market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Hyperpigmentation Disorder Treatment Market – Key Market Dynamics
4.1 Europe Hyperpigmentation Disorder Treatment Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Rise in Prevalence of Melasma
4.2.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
4.3 Market Restraints
4.3.1 High Cost of Treatments
4.4 Market Opportunities
4.4.1 Strategic Initiatives by Market Players
4.5 Future Trends
4.5.1 Use of Ablative Lasers
4.5.2 Novel Products Based on PATH-3 Technology
4.6 Impact of Drivers and Restraints:
5. Hyperpigmentation Disorder Treatment Market – Europe Analysis
5.1 Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030
6. Europe Hyperpigmentation Disorder Treatment Market Analysis – by Treatment Type
6.1 Cosmeceutical
6.1.1 Overview
6.1.2 Cosmeceutical: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
6.2 Light or Laser Therapy
6.2.1 Overview
6.2.2 Light or Laser Therapy: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Microdermabrasion
6.3.1 Overview
6.3.2 Microdermabrasion: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Chemical Peels
6.4.1 Overview
6.4.2 Chemical Peels: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Cryotherapy
6.5.1 Overview
6.5.2 Cryotherapy: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Others: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe Hyperpigmentation Disorder Treatment Market Analysis – by Condition
7.1 Melasma
7.1.1 Overview
7.1.2 Melasma: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Solar Lentigines
7.2.1 Overview
7.2.2 Solar Lentigines: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Post-inflammatory Hyperpigmentation
7.3.1 Overview
7.3.2 Post-inflammatory Hyperpigmentation: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Hyperpigmentation Disorder Treatment Market Analysis – by End User
8.1 Hospitals
8.1.1 Overview
8.1.2 Hospitals: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Dermatology Centers
8.2.1 Overview
8.2.2 Dermatology Centers: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Hyperpigmentation Disorder Treatment Market – Country Analysis
9.1 Europe Hyperpigmentation Disorder Treatment Market
9.1.1 Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
9.1.1.1 Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
9.1.1.2 Germany
9.1.1.3 Germany: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.3.2 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.3.3 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.4 UK
9.1.1.5 UK: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.1 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.5.2 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.5.3 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.6 France
9.1.1.7 France: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.7.1 France: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.7.2 France: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.7.3 France: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.8 Italy
9.1.1.9 Italy: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.9.1 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.9.2 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.9.3 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.10 Spain
9.1.1.11 Spain: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.11.1 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.11.2 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.11.3 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.12 Rest of Europe
9.1.1.13 Rest of Europe: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.1.1.13.1 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.13.2 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.13.3 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
10. Hyperpigmentation Disorder Treatment Market – Industry Landscape
10.1 Overview
10.2 Growth Strategies in Hyperpigmentation Disorder Treatment Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 AbbVie Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 EpiPharm AG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Galderma SA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Obagi Cosmeceuticals LLC
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Bayer AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Lutronic Co Ltd
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 L’OREAL S.A.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Pierre Fabre SA
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Research Team
12.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Hyperpigmentation Disorder Treatment Market Segmentation
Table 2. Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment Type
Table 3. Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Condition
Table 4. Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 5. Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Country
Table 6. Germany: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment Type
Table 7. Germany: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Condition
Table 8. Germany: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 9. UK: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment Type
Table 10. UK: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Condition
Table 11. UK: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 12. France: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment Type
Table 13. France: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Condition
Table 14. France: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 15. Italy: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment Type
Table 16. Italy: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Condition
Table 17. Italy: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 18. Spain: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment Type
Table 19. Spain: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Condition
Table 20. Spain: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 21. Rest of Europe: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment Type
Table 22. Rest of Europe: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Condition
Table 23. Rest of Europe: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 24. Recent Organic Growth Strategies in Hyperpigmentation Disorder Treatment Market
Table 25. Recent Inorganic Growth Strategies in the Hyperpigmentation Disorder Treatment Market
Table 26. Glossary of Terms, Hyperpigmentation Disorder Treatment Market

LIST OF FIGURES

Figure 1. Europe Hyperpigmentation Disorder Treatment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030
Figure 4. Europe Hyperpigmentation Disorder Treatment Market Share (%) – by Treatment Type (2022 and 2030)
Figure 5. Cosmeceutical: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Light or Laser Therapy: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Microdermabrasion: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Chemical Peels: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Cryotherapy: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Europe Hyperpigmentation Disorder Treatment Market Share (%) – by Condition (2022 and 2030)
Figure 12. Melasma: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Solar Lentigines: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Post-inflammatory Hyperpigmentation: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Hyperpigmentation Disorder Treatment Market Share (%) – by End User (2022 and 2030)
Figure 17. Hospitals: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Dermatology Centers: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Hyperpigmentation Disorder Treatment Market, By Key Country – Revenue (2022) (US$ Million)
Figure 21. Europe Hyperpigmentation Disorder Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 22. Germany: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. UK: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. France: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Italy: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Spain: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Rest of Europe: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Growth Strategies in Hyperpigmentation Disorder Treatment Market

The List of Companies – Europe Hyperpigmentation Disorder Treatment Market

o AbbVie Inc
o Bayer AG
o EpiPharm AG
o Galderma SA
o L’OREAL S.A.
o Lutronic Co Ltd
o Obagi Cosmeceuticals LLC
o Pierre Fabre SA

Reviews

There are no reviews yet.

Be the first to review “Europe Hyperpigmentation Disorder Treatment Market Forecast to 2030”